Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Diplomat receives distribution contract for Zydelig Diplomat, the nation's largest independent specialty pharmacy, has been selected as a provider of Zydelig tablets. Zydelig was approved by the U.S. Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers.
Contract Research & Services > Contract Services > News
Onco360 named to Zydelig limited distribution network Onco360, the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services company, has announced that it has been selected to be part of the highly limited Specialty Pharmacy network of Zydelig (idelalisib) tablets. PharMerica Corporation (PMC) is a significant investor in Onco360.
Contract Research & Services > Contract Services > News BioSyent signs licensing deal for new urgent care drug product By PBR Staff Writer
BioSyent Pharma has signed an exclusive licensing and distribution agreement with an existing European partner for a new product that will be marketed by its Hospital Products Division.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Sinovac receives Beijing CDC tender to supply seasonal flu vaccine Anflu
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention to be a supplier of the seasonal influenza vaccine to the citizens of Beijing for 2014.
Contract Research & Services > Contract Services > News
Puma Biotechnology revises Neratinib licensing deal with Pfizer
By PBR Staff Writer
US-based biopharmaceutical firm Puma Biotechnology has revised its licensing agreement with Pfizer for Puma's investigational drug PB272 (neratinib).
Contract Research & Services > Contract Services > News
Iroko Pharmaceuticals, CALOX partner to commercialize Zorvolex in Latin America
By PBR Staff Writer
US-based Iroko Pharmaceuticals has signed a licensing agreement with CALOX DE COSTA RICA for exclusive rights to market and sell Zorvolex (diclofenac) capsules in specified countries in Latin America.
Contract Research & Services > Contract Services > News
Arena subsidiary inks marketing, supply deal with Abic for BELVIQ in Israel
By PBR Staff Writer
Arena Pharmaceuticals' subsidiary has entered into an exclusive marketing and supply agreement for BELVIQ (lorcaserin HCl) with Teva Pharmaceutical Industries' Israeli subsidiary, Abic Marketing Limited.
Contract Research & Services > Contract Services > News
Anacor Pharmaceuticals, Sandoz ink deal to commercialize KERYDIN in US
Anacor Pharmaceuticals has entered into an exclusive agreement with Sandoz, a Novartis company, pursuant to which Sandoz will distribute and commercialize Anacor’s drug KERYDIN (tavaborole) topical solution, 5% in the United States.
Contract Research & Services > Contract Services > News
Celladon announces In-license of stem cell factor development program
Celladon, a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation has announced an exclusive, global license from Enterprise Partners Venture Capital for gene therapy applications of the membrane-bound form of the Stem Cell Factor gene (mSCF) for treatment of cardiac ischemia.
Contract Research & Services > Contract Services > News
Lannett inks deal with Symplmed for US distribution of authorized generic of ACEON
By PBR Staff Writer
US-based Lannett has signed an agreement with Symplmed Pharmaceuticals to be the exclusive distributor in the US of an authorized generic version of ACEON (perindopril erbumine tablets) in 2mg, 4mg and 8mg dosage strengths.
Contract Research & Services > Contract Services > News
Mymetics to manufacture Imugene's Virosome based HER-Vaxx cancer immunotherapy
By PBR Staff Writer
Swiss biotechnology firm Mymetics has signed an exclusive agreement with Imugene, an Australian biopharmaceutical company, to manufacture and develop its cancer immunotherapy HER-Vaxx.
Contract Research & Services > Contract Services > News
MediWound announces NexoBrid marketing approval from Israeli Ministry of Health
MediWound has received authorization from the Israeli Ministry of Health to market and distribute NexoBrid for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns. MediWound intends to launch NexoBrid in Israel this quarter.
Contract Research & Services > Contract Services > News
Isis Pharmaceuticals earns $1 million from GSK for advancing ISIS-TTR Rx
Isis Pharmaceuticals has announced that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250